Abstract
The Customs Union of Belarus, Kazakhstan and Russia is a form of trade and economic integration of Belarus, Kazakhstan and Russia which provides a unified customs territory within the mutual trade in goods and does not apply customs duties and economic restrictions, except for special protective, antidumping and countervailing measures. The Republics of Belarus and Kazakhstan and the Russian Federation, in accordance with the Agreement of October 6, 2007, established the Commission of the Customs Union, a single permanent regulatory agency of the Customs Union. At present the Commission of the Customs Union is expected to sign the Agreement on common principles of the circulation of goods and services (which includes drug products). In connection with this Agreement which contains an approach to prepare a unified guidance for BE studies, a plan for document preparation has been approved (a Custom Union BE guidance was approved in May 2017).
References
Ramenskaya GV, Shokhin IE. Modern approaches to quality evaluation of generic drug products for their registration (a review). Pharm Chem J. 2010;43(9):512–5.
Davydova KS, Shokhin IE, Ramenskaya GV, Kukes VG. Interchangeability evaluation for generic drug products. Remedium. 2010;7:36–8.
Strategy of Development of the pharmaceutical industry in the Russian Federation for the period until 2020 (Pharma-2020 Strategy) official documents. – M.., 2009 г. http://www.minpromtorg.gov.ru/ministry/strategic/sectoral/7/utverzhdennaya_strategiya_farma2020_231009.pdf (accessed date 02.05.2014).
Federal Law of April 12, 2010 N 61-FZ “Circulation of Medicines” 2010.
URL: grls.rosminzdrav.ru (accessed date 02.05.2014).
Methodical instructions for BE studies. – M., 2001.
Methodical instructions for BE studies. – M., 2004.
Methodical instructions for BE studies. – M., 2008.
Guidelines for the Expertise of Drugs. Vol. I. – M.: Grif&K, 2013. – 328 p.
National Standard GOST R 52379–2005 “Good Clinical Practice”.
Guideline on the investigation of BE. CPMP/EWP/QWP/1401/98 Rev. 1/ Corr. – EMA, 2010.
Guideline on bioanalytical method validation. EMEA/CHMP/EWP/192217/2009 – EMA, 2011.
Godovalnikov GV, Voronov GG. Instruction for registration requirements and rules for equivalence studies for generic drug products. Approved by Ministry of Healthcare of the Republic of Belarus 30.05.01, Reg No 73–0501. – Minsk, 2001. 25 p.
State Pharmacopoeia for the Republic of Belarus, IInd edition. Vol. 1. Registration requirements and rules for BE studies for generic drug products. / Ministry of Healthcare of the Republic of Belarus; edited by. A.A. Sheriakov. – Molodechno, Pobeda, 2012. p. 1092–130.
CPMP/EWP/QWP/1401/98Rev.1 Guidance on the Investigation of Bioequivalence. – London, 2010. p. 1–27.
Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability/WHO Technical Report Series, No. 937, 2006. p. 347–90.
Moore JW, Flanner HH. Mathematical comparison of curves with an emphasis on in vitro dissolution profiles. Pharm Technol. 1996;20(6):64–74.
Coasta P, Sousa LJM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–33.
Code of Health and the health care system of the Republic of Kazakhstan. 2009.
Order of the Ministry of Health № 744, (The rules of clinical researches and (or) pharmacological and medicinal drugs, medical products and medical equipment), 2009.
Order of the Ministry of Health № 442, (Approving the rules of preclinical researches, medico-biological experiments and clinical studies in the Republic of Kazakhstan), 2007.
Guideline “Conducting of good BE studies for drug products in the Republic of Kazakhstan” 2007.
Guidance for Bioequivalence Studies of Generic Drug Products on the Territory of the Eurasian Economic Union 2015. http://www.eurasiancommission.org/ru/act/texnreg/deptexreg/konsultComitet/Documents/Правила БЭИ итог 20.02.2015 на сайт.pdf.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Shohin, I.E., Rozhdestvenskiy, D.A., Medvedev, V.Y., Komarov, T.N., Grebenkin, D.Y. (2017). Russia, Belarus & Kazakhstan. In: Kanfer, I. (eds) Bioequivalence Requirements in Various Global Jurisdictions. AAPS Advances in the Pharmaceutical Sciences Series, vol 28. Springer, Cham. https://doi.org/10.1007/978-3-319-68078-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-68078-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68077-4
Online ISBN: 978-3-319-68078-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)